-
1 Comment
GX Acquisition Corp is currently in a long term downtrend where the price is trading 1.6% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
GX Acquisition Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 558.7% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 8.3% to $-242K since the same quarter in the previous year.
Based on the above factors, GX Acquisition Corp gets an overall score of 1/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US1511901050 |
| Sector | Financial Services |
| Industry | Shell Companies |
| Dividend Yield | 0.0% |
|---|---|
| Market Cap | 202M |
| PE Ratio | None |
| Target Price | None |
| Beta | nan |
Celularity Inc., a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GXGX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
